HHS-OIG and FBI investigated our client, the former director of a national laboratory, for Healthcare Fraud and Money Laundering based on their alleged participation in a scheme to defraud Medicare of approximately $100 million in reimbursements for not-medically-necessary molecular testing and violating the federal anti-kickback statute. After conducting our own investigation into the matter and presenting the evidence to the investigating agents and prosecutors, we convinced the Government not to prosecute.